PRELUDE THERAPEUTICS INC shareholders Q2 2023

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.

PRELUDE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Nuveen Asset Management, LLC 13,804$62,1180.00%
HighMark Wealth Management LLC 50$2250.00%
Tower Research Capital LLC (TRC) 2,090$9,4050.00%
Cutler Group LLC / CA 130$00.00%
JPMORGAN CHASE & CO 9,339$42,0260.00%
BARCLAYS PLC 6,052$270.00%
ROYAL BANK OF CANADA 5,279$24,0000.00%
D. E. Shaw & Co., Inc. 55,838$251,2710.00%
VANGUARD GROUP INC 952,938$4,288,2210.00%
Mirae Asset Global Investments Co., Ltd. 10,087$45,3920.00%
Ameritas Investment Partners, Inc. 819$3,6860.00%
TD ASSET MANAGEMENT INC 80,326$361,4670.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 3,297$14,8370.00%
UBS Group AG 6,892$31,0150.00%
RHUMBLINE ADVISERS 29,819$134,1850.00%
Squarepoint Ops LLC 19,127$86,0720.00%
TWO SIGMA INVESTMENTS, LP 39,290$176,8050.00%
DIMENSIONAL FUND ADVISORS LP 14,131$63,6040.00%
External links

This page lists PRELUDE THERAPEUTICS INC's shareholders in Q2 2023. To view PRELUDE THERAPEUTICS INC's shareholder history, click here.